GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (OTCPK:OLYMY) » Definitions » 12-1 Month Momentum %

Olympus (Olympus) 12-1 Month Momentum % : -19.06% (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Olympus 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-27), Olympus's 12-1 Month Momentum % is -19.06%.

The industry rank for Olympus's 12-1 Month Momentum % or its related term are showing as below:

OLYMY's 12-1 Month Momentum % is ranked worse than
52.46% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: -17.465 vs OLYMY: -19.06

Competitive Comparison of Olympus's 12-1 Month Momentum %

For the Medical Instruments & Supplies subindustry, Olympus's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus's 12-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Olympus's 12-1 Month Momentum % falls into.



Olympus  (OTCPK:OLYMY) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olympus  (OTCPK:OLYMY) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Olympus 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Olympus's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus (Olympus) Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.

Olympus (Olympus) Headlines

From GuruFocus

David Herro Comments on Olympus Corp.

By Holly LaFon 04-23-2013

Olympus's Net-Zero Targets Approved by SBTi

By ACN Newswire 11-30-2023

Olympus Announces Leadership Succession Plan

By ACN Newswire ACN Newswire 10-21-2022

T. Rowe Price Japan Fund's Top 5 New Buys

By Holly LaFon Holly LaFon 07-17-2013

David Herro Comments on Olympus

By Holly LaFon Holly LaFon 10-10-2016

David Herro's Oakmark International Fund 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood 04-08-2020